| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
Departments of Surgery,1 Microbiology and Immunology,2 Pathology,6 Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, 3601 4th St., Lubbock, Texas 79430,7 Life Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720,3 Department of Bioengineering, Rice University, 6100 Main, Houston, Texas 77005,4 Department of Biological Sciences, Auburn University, 319 Life Sciences Building, Auburn, Alabama 368495
Received 23 April 2007/ Accepted 29 May 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The differentiation or maturation of P. aeruginosa biofilms in vitro depends on intercellular signaling systems or quorum sensing (QS) (5, 22). QS systems in many gram-negative bacteria rely on acylated homoserine lactones (AHLs), which are produced at high levels when cell density is high and act as ligands for transcriptional regulators. The P. aeruginosa synthases LasI and RhlI synthesize two AHLs, N-3-oxododecanoyl homoserine lactone (3OC12-HSL) and N-butyryl-homoserine lactone (C4-HSL), which bind and modulate the activity of the transcriptional regulators LasR and RhlR, respectively (28). These transcriptional regulators then regulate the transcription of many genes whose products, including proteases, elastases, toxins, and hemolysins, are thought to be crucial for virulence (28). P. aeruginosa strains lacking functional QS systems are less virulent than wild-type strains (29) and form flat, undifferentiated biofilms on glass surfaces (5). These undifferentiated biofilms are less stable than the differentiated biofilms formed by wild-type P. aeruginosa as they can be easily disrupted by the detergent sodium dodecyl sulfate (5). However, the role of QS in biofilm formation has not previously been examined in vivo. Therefore, in this study we have also examined the role of QS in P. aeruginosa biofilm formation in the acute infection model.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Thermally injured mouse model. P. aeruginosa was examined in the thermally injured mouse model as previously described (12, 29). Mice were housed and studied under protocols approved by the Institutional Animal Care and Use Committee in the animal facility of Texas Tech University Health Sciences Center (Lubbock, TX).
Construction of alginate-deficient mutant. An alginate-deficient mutant of P. aeruginosa was constructed as follows. Briefly, approximately 2,380 nucleotides of a DNA fragment carrying 1,131 nucleotides of the algD open reading frame and 1,050 nucleotides of the flanking sequences was PCR amplified from strain FRD1, a cystic fibrosis isolate of P. aeruginosa. The DNA was amplified with the thermostable DNA polymerase Pfu (Stratagene, La Jolla, CA) to avoid potential errors. The amplified algD fragment was cloned into pUC19 as a BamHI-HindIII fragment, and moriT (36) was subcloned as a HindIII fragment to make the plasmid conjugable. The resulting plasmid, pSS336, was further digested with BclI to delete approximately 510 nucleotides from the algD open reading frame, and a nonpolar tet cassette that codes for tetracycline resistance (36) was inserted into the Bcl site as a BamHI fragment in the same orientation as the algD gene to generate the algD1301::tet deletion allele. To construct an algD deletion mutant, the plasmid carrying the deletion allele (pSS350) was introduced into PAO1 via triparental mating as previously described (35) and the resulting exconjugants that had undergone allelic exchange were selected by tetracycline resistance, screened for carbenicillin sensitivity, and verified by PCR amplification of the mutant allele. To complement the algD deletion, pALG2, which carries the complete alginate operon (20), was introduced into the algD mutant via triparental mating and selected for carbenicillin resistance. Because pALG2 cannot replicate autonomously in P. aeruginosa, the plasmid integrated into the genome via homologous recombination.
Sample preparation, microscopy, and image analysis. Confocal scanning laser microscopy (CSLM), transmission electron microscopy (TEM), scanning electron microscopy (SEM), and fluorescence microscopy were used to examine tissue sections for biofilm formation. For CSLM tissue sections were removed after euthanasia from the underlining burned tissue using a scalpel, washed in sterile PBS, and placed in imaging chambers (Molecular Probes, Eugene, OR) containing an antifade reagent (Molecular Probes). CSLM and fluorescent images were obtained using an Olympus IX71 upright microscope equipped with the Fluoview 300 CSLM package (Olympus America, Melville, NY). Image analysis and reconstruction were performed using MetaMorph 6.1 (Universal Imaging Corporation, PA) and COMSTAT (13) software. Bright-field images were acquired using a Nikon DXM1200 color digital camera equipped with the ACT-1 software analysis package (Nikon, Melville, NY). Skin tissue was prepared for SEM by being fixed overnight at 4°C in 1.5% glutaraldehyde and 3% paraformaldehyde in 0.1 M Millonig's buffer with dextrose. Tissue was then frozen in liquid nitrogen and fractured with a frozen blade to expose more surface. Tissues were postfixed in 1% osmium tetroxide, taken through a graded series of alcohols, and critically point dried. The sections were mounted on edge on stubs coated with carbon tape and gold coated. Images were acquired with a Hitachi S-500 scanning electron microscope (Hitachi America, Ltd., Brisbane, CA). TEM with ruthenium red staining was performed as previously described (11), and images were viewed with a Hitachi H600 transmission electron microscope. Fluorescence imaging of perivascular cuffing (PVC) was performed on paraformaldehyde-fixed tissue sections using a fluorescence in situ hybridization (FISH) probe specific for P. aeruginosa (5'-Cy3/GCTGGCCTAGCCTTC-3' [IDT, Coralville, IA]) as previously described (38). Fluorescence immunohistochemistry for alginate was performed on formalin-fixed paraffinized tissues. The tissues were deparaffinized, treated for 15 min with 20-µg/ml proteinase K, and incubated overnight at 4°C in a 1:100 dilution of human antialginate monoclonal antibody (G. B. Pier, Harvard Medical School/Brigham and Women's Hospital). Tissue sections were then rinsed three times for 10 min each in PBST (PBS plus 0.1% Tween 20) and incubated for 1 h at room temperature with a 1:30 dilution of anti-human Alexa Fluor 488 antibody (Molecular Probes). Sections were rinsed three times for 10 min each in PBST and imaged as described above. For TEM visualization of alginate, tissue sections were fixed in 4% paraformaldehyde in Dulbecco's PBS. Samples were cut with a 1-mm punch biopsy instrument, high pressure frozen using 200-µm-deep aluminum planchettes in a BAL-TEC HPM-010 high-pressure freezer, and stored under liquid nitrogen (4, 18). Samples were freeze substituted in 0.2% anhydrous glutaraldehyde and 0.1% uranyl acetate in acetone using a Leica EM AFS and subsequently embedded in LR White using microwave polymerization (17). One-hundred-nanometer thin sections were cut for immunolabeling on 200-mesh, Formvar- and carbon-coated nickel grids and subsequently labeled with primary antialginate antibody (polyclonal rabbit antialginate; G. B. Pier, Harvard Medical School/Brigham and Women's Hospital) at 1:200 dilution in a blocking buffer containing bovine serum albumin and cold water fish gelatin overnight at 4°C, followed by 10-nm-gold secondary antibody (Electron Microscopy Sciences) at 1:20 dilution for 1 h at room temperature. Sections were poststained for 4 min using 2% uranyl acetate in 70% methanol and imaged on a Philips CM200 transmission electron microscope at 200 keV with a Tietz TemCam F214 charge-coupled device.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
P. aeruginosa forms microcolonies in burned tissue by 8 h post-burn/infection. Tissues were harvested from the burn eschar at 8, 24, and 46 h post-burn/infection. A third-degree burn completely destroys the ultrastructure of the epidermis and dermis, leaving only hypodermis, which is composed primarily of vascular, connective, muscle, and adipose tissues. Thus, the burned epidermis and dermis were peeled away, homogenized, and used to determine CFU (see Fig. S1 in the supplemental material). Thin layers (approximately 1 mm) of the hypodermis were rinsed in sterile PBS and placed directly on slides for image analysis. Small clusters or microcolonies of GFP-expressing bacilli were visualized by CSLM at 8 h post-burn/infection in all mice examined (n = 6) (Fig. 1A). Microcolonies ranged in size from 14 to 33 µm. The CFU in these tissues had increased from the starting dose of 102 to 4.4 x 107 ± 1.8 x 107 (see Fig. S1 in the supplemental material). Green fluorescence was not observed in burned but noninfected tissue samples or burned tissue infected with non-GFP-expressing PAO1 (data not shown). The CFU in the burned skin had increased to 1.3 x 109 ± 3.9 x 108 by 24 h post-burn/infection, and large bacterial aggregates or macrocolonies, ranging in size from 38 to 53 µm, were visualized in the tissues in 91% of the mice (10/11). These macrocolonies were primarily located surrounding adipocytes and veins (Fig. 1 and 2). All tissues harvested from PAO1-infected mice at 46 h post-burn/infection exhibited extensive surface coverage (n = 11), and aggregates measured 15 to 25 µm (Fig. 1). Individual bacterial cells that were not associated with structures were also observed at all time points (Fig. 1).
|
|
P. aeruginosa possesses an extracellular, alginate-associated matrix in vivo. Bacterial biofilms have been defined as groups of bacteria attached to a surface and enclosed in a matrix, typically made of polysaccharides, nucleic acids, and proteins (3). Our CSLM images revealed large aggregates of P. aeruginosa, which were not removed by rinsing the tissue (Fig. 1 and 2). P. aeruginosa aggregates were visualized by SEM and TEM of the burned tissue to determine if they were associated with a biofilm matrix (BFM) (Fig. 1B, 2D, and 3). SEM images revealed matrix-like structures and/or "bacterial flocs" in association with the P. aeruginosa aggregates (Fig. 1B). These structures are consistent with the polysaccharide BFMs that have been described in P. aeruginosa biofilms in vitro (38, 39). For visualization by TEM, tissue sections were treated with ruthenium red, a polyanionic stain that stabilizes the structural integrity of the polysaccharide-rich BFM, which can be lost during the dehydration process (10, 11). Ruthenium red-treated tissue, counterstained with uranyl acetate and lead citrate, revealed dark fiber-like structures between P. aeruginosa cells in TEM (Fig. 3), which are consistent with previously demonstrated biofilms (10, 11). These fibrous structures were not visualized in areas devoid of P. aeruginosa.
|
|
|
|
| ACKNOWLEDGMENTS |
|---|
This study was supported by the American Lung Association and South Plains Foundation (K.P.R.).
| FOOTNOTES |
|---|
Published ahead of print on 11 June 2007. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Beatson, S. A., C. B. Whitchurch, A. B. Semmler, and J. S. Mattick. 2002. Quorum sensing is not required for twitching motility in Pseudomonas aeruginosa. J. Bacteriol. 184:3598-3604. |
| 2. | Bragonzi, A., D. Worlitzsch, G. B. Pier, P. Timpert, M. Ulrich, M. Hentzer, J. B. Andersen, M. Givskov, M. Conese, and G. Doring. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419.[CrossRef][Medline] |
| 3. | Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. |
| 4. | Dahl, R., and L. A. Staehelin. 1989. High-pressure freezing for the preservation of biological structure: theory and practice. J. Electron Microsc. Tech. 13:165-174.[CrossRef][Medline] |
| 5. | Davies, D. G., M. R. Parsek, J. P. Pearson, B. H. Iglewski, J. W. Costerton, and E. P. Greenberg. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298. |
| 6. | De Kievit, T. R., R. Gillis, S. Marx, C. Brown, and B. H. Iglewski. 2001. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol. 67:1865-1873. |
| 7. | Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. |
| 8. | Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.[CrossRef][Medline] |
| 9. | Ehrlich, G. D., R. Veeh, X. Wang, J. W. Costerton, J. D. Hayes, F. Z. Hu, B. J. Daigle, M. D. Ehrlich, and J. C. Post. 2002. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 287:1710-1715. |
| 10. | Fassel, T. A., and C. E. Edmiston, Jr. 1999. Bacterial biofilms: strategies for preparing glycocalyx for electron microscopy. Methods Enzymol. 310:194-203.[CrossRef][Medline] |
| 11. | Fulcher, T. P., J. K. Dart, L. McLaughlin-Borlace, R. Howes, M. Matheson, and I. Cree. 2001. Demonstration of biofilm in infectious crystalline keratopathy using ruthenium red and electron microscopy. Ophthalmology 108:1088-1092.[CrossRef][Medline] |
| 12. | Haynes, A., III, F. Ruda, J. Oliver, A. N. Hamood, J. A. Griswold, P. W. Park, and K. P. Rumbaugh. 2005. Syndecan 1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect. Immun. 73:7914-7921. |
| 13. | Heydorn, A., A. T. Nielsen, M. Hentzer, C. Sternberg, M. Givskov, B. K. Ersboll, and S. Molin. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146:2395-2407. |
| 14. | Holloway, B. W., V. Krishnapillai, and A. F. Morgan. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102. |
| 15. | Leid, J. G., C. J. Willson, M. E. Shirtliff, D. J. Hassett, M. R. Parsek, and A. K. Jeffers. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518. |
| 16. | Mattick, J. S. 2002. Type IV pili and twitching motility. Annu. Rev. Microbiol. 56:289-314.[CrossRef][Medline] |
| 17. | McDonald, K. 1999. High-pressure freezing for preservation of high resolution fine structure and antigenicity for immunolabeling. Methods Mol. Biol. 117:77-97.[Medline] |
| 18. | Moor, H., G. Bellin, C. Sandri, and K. Akert. 1980. The influence of high pressure freezing on mammalian nerve tissue. Cell Tissue Res. 209:201-216.[Medline] |
| 19. | Musher, D. M. 1989. Cutaneous manifestations of bacterial sepsis. Hosp. Pract. 24:71-75, 80-82, 92 passim. |
| 20. | Ohman, D. E., and C. E. Chitnis. 1989. Genetic regulation of alginate structure in Pseudomonas aeruginosa. Antibiot. Chemother. 42:56-61.[Medline] |
| 21. | Oliver, J. W., and T. E. Debowski. 1998. Pseudomonas aeruginosa septicemia and associated cutaneous lesions. ASCP, Chicago, IL. |
| 22. | Parsek, M. R., and E. P. Greenberg. 1999. Quorum sensing signals in development of Pseudomonas aeruginosa biofilms. Methods Enzymol. 310:43-55.[Medline] |
| 23. | Pearson, J. P., K. M. Gray, L. Passador, K. D. Tucker, A. Eberhard, B. H. Iglewski, and E. P. Greenberg. 1994. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc. Natl. Acad. Sci. USA 91:197-201. |
| 24. | Pearson, J. P., E. C. Pesci, and B. H. Iglewski. 1997. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 179:5756-5767. |
| 25. | Pier, G. B. 1997. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Behring. Inst. Mitt. 98:350-360.[Medline] |
| 26. | Pier, G. B., D. Boyer, M. Preston, F. T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G. P. Priebe, M. Grout, M. Posner, and L. Cavacini. 2004. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J. Immunol. 173:5671-5678. |
| 27. | Pruitt, B. A., Jr., A. T. McManus, S. H. Kim, and C. W. Goodwin. 1998. Burn wound infections: current status. World J. Surg. 22:135-145.[CrossRef][Medline] |
| 28. | Rumbaugh, K. P., J. A. Griswold, and A. N. Hamood. 2000. The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbes Infect. 2:1721-1731.[CrossRef][Medline] |
| 29. | Rumbaugh, K. P., J. A. Griswold, B. H. Iglewski, and A. N. Hamood. 1999. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect. Immun. 67:5854-5862. |
| 30. | Singh, P. K., A. L. Schaefer, M. R. Parsek, T. O. Moninger, M. J. Welsh, and E. P. Greenberg. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764.[CrossRef][Medline] |
| 31. | Slusher, M. M., Q. N. Myrvik, J. C. Lewis, and A. G. Gristina. 1987. Extended-wear lenses, biofilm, and bacterial adhesion. Arch. Ophthalmol. 105:110-115.[Abstract] |
| 32. | Soave, R., H. W. Murray, and M. M. Litrenta. 1978. Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am. J. Med. 65:864-867.[CrossRef][Medline] |
| 33. | Stickler, D. J., N. S. Morris, R. J. McLean, and C. Fuqua. 1998. Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl. Environ. Microbiol. 64:3486-3490. |
| 34. | Stieritz, D. D., and I. A. Holder. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131:688-691.[Medline] |
| 35. | Suh, S. J., L. Silo-Suh, D. E. Woods, D. J. Hassett, S. E. West, and D. E. Ohman. 1999. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J. Bacteriol. 181:3890-3897. |
| 36. | Suh, S. J., L. A. Silo-Suh, and D. E. Ohman. 2004. Development of tools for the genetic manipulation of Pseudomonas aeruginosa. J. Microbiol. Methods 58:203-212.[CrossRef][Medline] |
| 37. | Tredget, E. E., H. A. Shankowsky, R. Rennie, R. E. Burrell, and S. Logsetty. 2004. Pseudomonas infections in the thermally injured patient. Burns 30: 3-26.[CrossRef][Medline] |
| 38. | Veeh, R. H., M. E. Shirtliff, J. R. Petik, J. A. Flood, C. C. Davis, J. L. Seymour, M. A. Hansmann, K. M. Kerr, M. E. Pasmore, and J. W. Costerton. 2003. Detection of Staphylococcus aureus biofilm on tampons and menses components. J. Infect. Dis. 188:519-530.[CrossRef][Medline] |
| 39. | Whiteley, M., M. G. Bangera, R. E. Bumgarner, M. R. Parsek, G. M. Teitzel, S. Lory, and E. P. Greenberg. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413:860-864.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|